AXT Inc. (NASDAQ:AXTI), a manufacturer of compound semiconductor substrates, reported financial results for the fourth quarter and full fiscal year 2025 that fell short of analyst expectations, leading to a sharp decline in its share price in after-hours trading.
The company’s performance was hampered by operational challenges, notably a delay in receiving export permits for its China-based manufacturing. However, management struck an optimistic tone regarding the current year, positioning the company as a beneficiary of the ongoing build-out in artificial intelligence infrastructure.
Quarterly Financial Performance vs. Estimates
AXT’s fourth-quarter results missed consensus forecasts on both the top and bottom lines. Revenue declined both sequentially and year-over-year, reflecting the impact of the permit delays.
- Revenue: Reported at $23.0 million, compared to analyst estimates of $25.7 million.
- Earnings Per Share (Non-GAAP): Reported a loss of $0.05 per share, which was slightly better than the estimated loss of $0.0585 per share.
The company's gross margin showed some resilience on a quarterly basis, improving to 20.9% from 17.6% in the prior-year period, though it dipped slightly from 22.3% in the third quarter of 2025.
Full-Year 2025 Results and Market Context
The full-year picture underscores a challenging period for AXT. Fiscal 2025 revenue decreased to $88.3 million from $99.4 million in 2024. More significantly, profitability metrics deteriorated sharply, with the company swinging from a non-GAAP net income of $8.5 million in 2024 to a non-GAAP net loss of $18.0 million in 2025. The annual gross margin contracted to 12.7% from 24.0% a year earlier.
The market reaction was decisively negative following the report. Shares fell approximately 7.6% in after-market trading, indicating investor disappointment with the quarterly miss and the weak annual results, despite the narrower-than-expected quarterly loss.
Management Outlook and Strategic Focus
In the earnings release, CEO Morris Young addressed the near-term headwinds while outlining a growth strategy centered on AI and expanded manufacturing capacity.
- Near-Term Recovery: Young stated that the company has begun receiving export permits in 2026 and believes it is "in a strong position to achieve sequential revenue growth in Q1." This growth is expected to be "driven primarily by growth in indium phosphide (InP) for the AI infrastructure build-out."
- Strategic Initiatives: The company highlighted it is broadening its customer base to include Tier-1 companies and remains on track to double its indium phosphide manufacturing capacity in 2026. Management also emphasized a strong balance sheet to support expansion.
Forward Estimates vs. Management Commentary
Management’s qualitative guidance for sequential growth in the first quarter aligns with, but does not specifically quantify against, current analyst models. The provided consensus estimates for the coming periods are as follows:
- Q1 2026: Analysts expect a loss of $0.0306 per share on revenue of $27.3 million.
- Full-Year 2026: Analysts project a loss of $0.022 per share on revenue of $124.8 million.
The company’s ability to meet or exceed these estimates will likely depend on the pace of permit approvals and the materialization of expected demand from AI infrastructure projects.
Balance Sheet and Corporate Development
AXT’s balance sheet shows significant liquidity, with cash and cash equivalents rising to $120.3 million at year-end, up from $22.8 million a year ago. This increase is largely attributable to a capital raise. The company also provided an update on the long-pending initial public offering of its Beijing subsidiary, Tongmei, on China’s STAR Market, noting the process remains subject to regulatory approvals.
Conclusion
AXT’s fourth-quarter earnings report presented a mixed but challenging snapshot. While the company missed revenue targets for the quarter and posted a difficult full-year 2025, management is directing investor attention toward a recovery in 2026 fueled by AI-driven demand for its indium phosphide products. The immediate market reaction, however, focused on the earnings miss and annual profit decline. Investors will be closely monitoring the company’s execution in the first quarter to see if it can deliver the promised sequential growth and begin to capitalize on its strategic positioning in the AI supply chain.
For detailed historical earnings data and future analyst estimates, visit the AXT earnings and estimates page on Chartmill.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, nor does it recommend buying or selling any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
